DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Knoop AS, Knudsen H, Balslev E et al.
Retrospective analysis of topoisomerase II a amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group.
J Clin Oncol 2005;
23: 7483-7490
DOI: 10.1200/JCO.2005.11.007.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.